Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The hypothesis underlying this work is the identification of different sub phenotypes of patients with infective endocarditis through the study of the host's response to infection.
Furthemore, metagenomic sequencing may be a helpful supplement to IE diagnostic, especially when conventional tests fail to yield a diagnosis.
Infective endocarditis is a life-threatening infection of heart valves and adjacent structures characterized by vegetations on valves and other endocardial surfaces, with tissue destruction and risk of embolization.
The clinical variability, including the heterogeneous response to infection and the different antibiotic treatments make the identification of the underlying pathogens of infective endocarditis (IE) is critical for precision therapy. Virulence factors mediate tissue adherence, host infiltration, immune resistance/evasion, and dynamic stress responses and confer enhanced pathogen survival, proliferation, and host invasion in animal models of infective endocarditis.
To identify the microorganism and simultaneously considered the response of the host to the infection could improve the management of the infective endocarditis.
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| To characterize a cohort of patients diagnosed with infective endocarditis | Clinical, microbiological and echocardiographic description of patients with infective endocarditis. | 2 year |
| Measure | Description | Time Frame |
|---|---|---|
| Identification of the underlying pathogens of infective endocarditis (IE) | We will employ next-generation sequencing for pathogens and antimicrobial resistance detection in IE patients. | 2 year |
| Host response classification for infective endocarditis (IE) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Patients with an active infective endocarditis
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Guillermo Muñiz Albaiceta, MD, PhD | HUCA-FINBA, Universidad de Oviedo | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Hospital Universitario Central de Asturias | Oviedo | Principality of Asturias | 33011 | Spain |
All datasets underlying the study are available upon request to the study principal investigator.
All of the individual participant data collected during the trial, informed consent forms, study protocol, statistical analysis plan and raw data, are available under reasonable request, and after deindentification.
Starting 3 month after publication
Principal investigator will review requests of data to be provided.
Not provided
Not provided
| ID | Term |
|---|---|
| D004696 | Endocarditis |
| D000210 | Acute-Phase Reaction |
| ID | Term |
|---|---|
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |
| D007249 | Inflammation |
| D010335 | Pathologic Processes |
Not provided
Not provided
Not provided
Not provided
Not provided
Samples with DNA for the study of the host's sub phenotypes Plasma and heart valves to make a metagenomic sequencing
Differential baseline expression of some genes may indicate resilience to infection. |
| 2 year |
| Host response predictors of sepsis outcomes | We will develop and use advanced bioinformatic, metabolomic, proteomic and mRNA sequencing technologies to identify specific changes, or biomarkers, in patient blood samples that predict outcome in sepsis. | 2 year |
| D013568 |
| Pathological Conditions, Signs and Symptoms |